Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 May;114(4):651-6.
doi: 10.1007/BF02244997.

Effects of (R)-alpha-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze

Affiliations

Effects of (R)-alpha-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze

C P Smith et al. Psychopharmacology (Berl). 1994 May.

Abstract

The effects of (R)-alpha-methylhistamine ((R)-alpha-MeHA, a selective H3-receptor agonist) and scopolamine (SCOP, a muscarinic antagonist) were investigated on spatial learning and memory in the rat (Hooded Lister) using a water maze (WM). (R)-alpha-MeHA treatment (6.3 and 10 mg/kg IP) had no apparent effect on spatial learning but did result in enhanced spatial recall at the higher dose, assessed by a transfer (probe) test after training. In contrast, SCOP (0.5 mg/kg IP) induced a learning and memory deficit measured both during and after training. In animals treated with (R)-alpha-MeHA and SCOP, (R)-alpha-MeHA partially (6.3 mg/kg) and completely (10 mg/kg) reversed the SCOP-induced deficit during the training phase, while in the post-training transfer test, (R)-alpha-MeHA (10 mg/kg) significantly reduced the SCOP-induced memory deficit. None of the treatments described resulted in impaired visual acuity as demonstrated by a raised platform test. These results are consistent with a role for histamine in cognitive processes and suggest a possible interaction between central histamine and cholinergic mechanisms associated with rodent spatial learning and memory.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neuroscience. 1985 Jun;15(2):553-62 - PubMed
    1. Arch Int Pharmacodyn Ther. 1988 Jan-Feb;291:202-7 - PubMed
    1. Methods Find Exp Clin Pharmacol. 1992 Jan-Feb;14(1):35-40 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):513-9 - PubMed
    1. Synapse. 1991 Feb;7(2):151-68 - PubMed

LinkOut - more resources